The VitaDAO Genesis hoodie is now available

Order now

We fund exceptional science to build companies with long term impact

VitaDAO is a globally distributed, community-owned collective that funds and incubates translational aging research with a view to commercialise the resulting IP. We're fully independent and self-governed, which means we back research that others don't. We fund novel projects that present higher risk, but have the potential to make revolutionary contributions to science.


Join our community of longevity biotech researchers, builders and funders who are here to support you from application, to project funding and beyond.

$4M

Research Funded

20

Research Projects Funded

$6M+

Liquid Funds

9000+

Community Members

Why VitaDAO?

Faster, more transparent funding

VitaDAO's Longevity Dealflow team works with you to ensure a swift and uncomplicated funding application process. A dedicated community member becomes your single point of contact to guide you throughout the application journey, and applications receive an answer within 2 weeks of submission.

We back research that others don’t

We believe in innovative, groundbreaking aging research. VitaDAO is fully independent and self-governed, which means we back moonshots: highly novel projects that present higher risk, but have the potential to make revolutionary contributions to science.

Support every step of the way

Our team works with you to incubate your research from the lab, help with your IP strategy, plan for commercialisation and get your project ready for building. The VitaDAO model is designed to ensure funded projects enjoy the best chance at successful commercialisation that our network can provide, giving you more time to focus on your work in the lab.

Community-backed Science

VitaDAO is a mission-aligned community of longevity enthusiasts and professional contributors. A large and diverse community means you benefit from access to funders, communicators, technologists, and a robust network of leading researchers, all working to advance longevity science in an open and collaborative way.

The VitaDAO funding process

Projects we’re developing
See all projectsSee all projects
IP-NFT

Matrix Bio

VitaDAO and the Gorbunova Lab are launching Matrix Bio, a cutting-edge research venture leveraging the anti-cancer and pro-longevity effects of high molecular weight hyaluronic acid from naked mole rat to human.

$ 300,000
raised
View Project
IP-NFT

Scheibye-Knudsen Lab

What if therapeutics to slow down the aging process and prevent age-related disease already existed? The Scheibye-Knudsen Lab will use advanced machine learning to crunch the data from 1.04 billion prescriptions to understand the impact of drugs on human lifespan.

$ 250,000
raised
View Project
Equity

Turn Biotechnologies

Turn Bio develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. They are reprogramming the epigenome – a network of chemical compounds and proteins controlling cell functions to restore capabilities that are lost with age.

$ 1,000,000
raised
View Project
IP-NFT

ARTAN Bio - Mutation-Specific Codon Suppression for Aging and Longevity

ARTAN is a biotechnology company developing first-in-class interventions to tackle the most frequent nonsense mutations implicated in a wide range of age-related diseases and cancers. These nonsense mutations induce premature stops of protein translation when occurring in coding regions.

$ 91,300
raised
View Project

A few of our partners at the cutting edge of longevity research

Our top scientific contributors
Diane Seimetz
Diane Seimetz
Entrepreneur, Board Member, Leading drug development & regulatory expert
https://www.linkedin.com/in/diane-seimetz-24567933/
Jean M. Herbert
Jean M. Herbert
Neurogeneticist at the Albert Einstein College of Medicine
https://twitter.com/replacing_aginghttps://hebertlab.einsteinmedneuroscience.org/
Marco Quarta
Marco Quarta
Co-Founder & CEO at Rubedo Life Sciences
https://twitter.com/MarcoQuarta12https://www.linkedin.com/in/marco4quarta/https://www.rubedolife.com/
Michael Baran
Michael Baran
Michael Baran, MBA, PHD is Executive Director, WRDM and Partner at Pfizer Ventures
https://www.linkedin.com/in/michaelbaran/https://www.pfizer.com/people/leadership/venture_investments/michael_baran-mba-phd
Morten Scheibye-Knudsen
Morten Scheibye-Knudsen
Laboratory founder and leading longevity scientist.
https://twitter.com/ScheibyeKnudsenhttps://www.linkedin.com/in/morten-scheibye-knudsen-1b30335/http://scheibye-knudsen.com/
Vera Gorbunova
Vera Gorbunova
Professor of Biology at University of Rochester and Co-director, Rochester Aging Research Center
https://www.linkedin.com/in/vera-gorbunova-64a97b46/https://www.sas.rochester.edu/bio/people/faculty/gorbunova_vera/
Viktor Korolchuk
Viktor Korolchuk
Reader in Molecular Cell Biology at Newcastle University
https://www.linkedin.com/in/viktor-korolchuk-37602113/
Vittorio Sebastiano
Vittorio Sebastiano
Associate Professor of Reproductive and Stem Cell Biology at Stanford
https://www.linkedin.com/in/vittorio-sebastiano-36605538/https://med.stanford.edu/stemcell/institutefaculty/sebastiano.html

Are you working on the next longevity science breakthrough?

More ways to get involved

The Longevity Prize

A series of prizes awarding outstanding proces in longevity research. The initiative aims to accelerate progress in the rejuvenation biotechnology field and encourage innovation. The Longevity Prize is crowdsourced and curated by leading industry experts - presented in partnership with Foresight Institute, Methuselah Foundation and Lifespan.io.

The Longevity Prize
Collage of people

The Longevity Fellowship

The Longevity Fellowship provides micro-grants of up to $2,000 USD to passionate individuals in the field of longevity science. The program offers a unique opportunity for scientists, students, and longevity enthusiasts to delve deeper into their research interests, attend conferences, and join programs such as the Longevity Biotech Fellowship.

INTRODUCING

An overlay journal curating the world’s most promising longevity research.